
AU  - Fricker, Simon P.
C7  - pp. 1-20
TI  - Nitrogen Monoxide (Nitric Oxide): Bioinorganic Chemistry
UR  - https://doi.org/10.1002/9781119951438.eibc2724
DO  - doi:10.1002/9781119951438.eibc2724
SP  - 1-20
KW  - nitrogen monoxide
KW  - nitric oxide
KW  - nitric oxide synthase
KW  - peroxynitrite
KW  - nitrosothiol
KW  - soluble guanylate cyclase
KW  - phosphodiesterase 5
KW  - hemoglobin
AB  - Abstract The discovery of nitrogen monoxide (nitric oxide, NO) as the vasodilator molecule endothelium-derived relaxing factor revealed a major physiological role for this simple diatomic molecule. We now know that NO regulates cardiovascular function, is a neurotransmitter, and is a component of the innate immune response to infection and cancer. The physiological effects of NO are mediated by its varied chemistry which includes redox chemistry and interaction with transition metals. NO can interact with iron-heme-containing proteins including hemoglobin and cytochrome c oxidase, and nonheme iron proteins such as aconitase and bacterial transcription regulatory proteins. NO reacts with superoxide to form the highly reactive peroxynitrite which decomposes to give the hydroxyl radical. Nitrosothiols, thiol adducts of NO, act to control NO release, and to shuttle NO between proteins and transport NO across cell membranes. NO is produced by one of three nitric oxide synthase (NOS) enzymes, endothelial NOS, neuronal NOS, and inducible NOS. Signaling functions are mediated via interaction with the heme-containing protein soluble guanylate cyclase (GC), which produces the cell signaling molecule cyclic guanosine monophosphate (cGMP). This, in turn, is hydrolyzed by phosphodiesterase 5 (PDE5), which turns off NO signaling. Perturbation in NO function contributes to the pathophysiology of many disease states. Endothelial dysfunction and subsequent reduced NO production contribute to hypertension and atherosclerosis. Excess NO is a mediator of inflammatory disease, and neurodegenerative disease, due in part to the production of peroxynitrite. The cardiovascular collapse observed in septic shock is caused by the vasodilator action of NO. Targeting the NO pathway theoretically provides many opportunities for therapeutic intervention. The NO donor drugs glyceryl trinitrate, isosorbide mononitrate, isosorbide dinitrate, and amyl nitrate are used to treat acute angina; and inhaled NO is used to treat persistent pulmonary hypertension in new born infants. Conversely, NOS inhibitors and NO scavengers have been explored to counteract NO as a mediator of disease. Though promising results have been obtained in animal models of disease these latter approaches have had little clinical success. However, targeting downstream of NO has been more successful with new clinically approved classes of drugs such as the inhibitors of PDE5 sildenafil, tadalafil, and vardenafil; and the stimulator of the NO receptor soluble GC, riociguat. It has become apparent that the biological actions, and biological chemistry, of NO are very complex. New opportunities for drug discovery could result from an improved understanding of the biology of NO.
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 ORAL ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
UR  - https://doi.org/10.1111/j.1600-6143.2006.01446.x
DO  - doi:10.1111/j.1600-6143.2006.01446.x
SP  - 65
EP  - 472
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
AU  - Ward, Peter A.
TI  - New approaches to the study of sepsis
JO  - EMBO Molecular Medicine
JA  - EMBO Mol Med
VL  - 4
IS  - 12
UR  - https://doi.org/10.1002/emmm.201201375
DO  - doi:10.1002/emmm.201201375
SP  - 1234
EP  - 1243
KW  - clinical trials
KW  - complement
KW  - interventions
KW  - mediators
KW  - sepsis
PY  - 2012
AB  - Abstract Models of sepsis have been instructive in understanding the sequence of events in animals and, to an extent, in humans with sepsis. Events developing early in sepsis suggest that a hyperinflammatory state exists, accompanied by a buildup of oxidants in tissues reflective of a redox imbalance. Development of immunosuppression and degraded innate and adaptive immune responses are well-established complications of sepsis. In addition, there is robust activation of the complement system, which contributes to the harmful effects of sepsis. These events appear to be associated with development of multiorgan failure. The relevance of animal models of sepsis to human sepsis and the failure of human clinical trials are discussed, together with suggestions as to how clinical trial design might be improved.
ER  - 

TY  - JOUR
TI  - II Joint Meeting of the German Society for Immunology (DGfl) and the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA), 10–13 September, 2019, Munich, Germany
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S1
UR  - https://doi.org/10.1002/eji.201970300
DO  - doi:10.1002/eji.201970300
SP  - 1
EP  - 306
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 26
IS  - S2
UR  - https://doi.org/10.1111/iju.14061
DO  - doi:10.1111/iju.14061
SP  - 5
EP  - 101
PY  - 2019
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 17
IS  - s4
UR  - https://doi.org/10.1111/j.1469-0691.2011.03558.x
DO  - doi:10.1111/j.1469-0691.2011.03558.x
SP  - S108
EP  - S668
PY  - 2011
ER  - 

TY  - JOUR
TI  - SUBJECT INDEX
JO  - Annals of the New York Academy of Sciences
JA  - Annals of the New York Academy of Sciences
VL  - 634
IS  - 1
UR  - https://doi.org/10.1111/j.1749-6632.1992.tb00009.x
DO  - doi:10.1111/j.1749-6632.1992.tb00009.x
SP  - 181
EP  - 577
PY  - 1992
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Neurogastroenterology & Motility
VL  - 20
IS  - s2
UR  - https://doi.org/10.1111/j.1365-2982.2008.01190.x
DO  - doi:10.1111/j.1365-2982.2008.01190.x
SP  - 1
EP  - 144
PY  - 2008
ER  - 

TY  - JOUR
TI  - Eighth Annual Meeting of the Wound Healing Society Little America Hotel Salt Lake City, Utah June 17–20, 1998
JO  - Wound Repair and Regeneration
JA  - Wound Repair and Regeneration
VL  - 6
IS  - 3
UR  - https://doi.org/10.1046/j.1524-475X.1998.60311.x
DO  - doi:10.1046/j.1524-475X.1998.60311.x
SP  - A241
EP  - A241
PY  - 1998
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 43
IS  - s1
UR  - https://doi.org/10.1111/eci.12060
DO  - doi:10.1111/eci.12060
SP  - 3
EP  - 96
PY  - 2013
ER  - 

TY  - JOUR
TI  - 17th European Workshop on the “Cell Biology of Phagocytes” May 27–31, 1998 Catania, Italy
JO  - European Journal of Haematology
VL  - 60
IS  - 5
UR  - https://doi.org/10.1111/j.1600-0609.1998.tb01051.x
DO  - doi:10.1111/j.1600-0609.1998.tb01051.x
SP  - 323
EP  - 351
PY  - 1998
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 83
IS  - S1
UR  - https://doi.org/10.1002/bjs.1800831302
DO  - doi:10.1002/bjs.1800831302
SP  - 1
EP  - 154
PY  - 1996
ER  - 

C7  - pp. 221-266
TI  - Hematopoietic System
SN  - 9780813817538
UR  - https://doi.org/10.1002/9780470344590.ch5
DO  - doi:10.1002/9780470344590.ch5
SP  - 221-266
KW  - hematopoietic system
KW  - metaclopramide
KW  - cyclooxygenase
KW  - erythematosus
KW  - stress test
PY  - 1996
AB  - Summary This chapter contains section titled: Hematopoiesis, Hematology, and Hemostasis Immune System Inflammation Ex Vivo Living Systems Cardiovascular: Ex Vivo Hepatic: Ex Vivo Hematopoietic: Lymphocytes (EX VIVO) Hematopoietic: Macrophages and Monocytes (EX VIVO) Hematopoietic: Neutrophils (EX VIVO) Hematopoietic: Platelets (EX VIVO) Hematopoietic: Red Blood Cells (EX VIVO) Musculoskeletal: Ex Vivo Neoplastic Disease: Ex Vivo Respiratory: Ex Vivo
ER  - 

TY  - JOUR
TI  - Swiss Society of Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 94
IS  - 6
SN  - 9780813817538
UR  - https://doi.org/10.1002/bjs.5859
DO  - doi:10.1002/bjs.5859
SP  - 761
EP  - 784
PY  - 2007
AB  - Abstract The following abstracts will be presented at the 94th Annual Congress of the Swiss Society of Surgery. The meeting, held in Lausanne, 13-15 June 2007, is organized for the fifth time in collaboration with the Swiss Society of Thoracic, Heart and Vascular Surgery.
ER  - 

TY  - JOUR
TI  - Poster Communications
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 218
IS  - S709
SN  - 9780813817538
UR  - https://doi.org/10.1111/apha.12779
DO  - doi:10.1111/apha.12779
SP  - 26
EP  - 91
PY  - 2016
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 9780813817538
UR  - https://doi.org/10.1111/tri.12210
DO  - doi:10.1111/tri.12210
SP  - 1
EP  - 184
PY  - 2013
ER  - 

TY  - JOUR
TI  - Symposium Summaries
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 45
IS  - S33
SN  - 9780813817538
UR  - https://doi.org/10.1002/ppul.21338
DO  - doi:10.1002/ppul.21338
SP  - 107
EP  - 219
PY  - 2010
ER  - 

TY  - JOUR
TI  - Subspecialty Poster Sessions
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 45
IS  - s2
SN  - 9780813817538
UR  - https://doi.org/10.1111/eci.12436
DO  - doi:10.1111/eci.12436
SP  - 69
EP  - 92
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session 2, Monday 6 September
JO  - European Journal of Neurology
VL  - 11
IS  - s2
SN  - 9780813817538
UR  - https://doi.org/10.1111/j.1468-1331.2004.00920.x
DO  - doi:10.1111/j.1468-1331.2004.00920.x
SP  - 183
EP  - 331
PY  - 2004
ER  - 
